Anthony C Caputa

Title: The Innovations of Anthony C. Caputa

Introduction: Anthony C. Caputa is a notable inventor based in Nanuet, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His work focuses on addressing critical health issues, such as Lyme disease.

Latest Patents: Anthony C. Caputa holds 1 patent for a recombinant vaccine against Lyme disease. This innovative vaccine features a highly-antigenic, recombinant polypeptide with a molecular weight of about 110-kD, as determined by SDS-PAGE. The polypeptide is derived from transforming E. coli with a 7.1 kB DNA fragment from EcoR1-digested B. burgdorferi DNA. The process includes the identification of cloned transformants that express polypeptides capable of binding to anti-B. burgdorferi antibodies.

Career Highlights: Caputa is affiliated with the Regents of the University of Minnesota, where he continues to advance his research and development efforts. His work has the potential to significantly impact public health by providing effective solutions to combat Lyme disease.

Collaborations: Throughout his career, Anthony has collaborated with esteemed colleagues, including Russell F. Bey and Michael P. Murtaugh. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion: Anthony C. Caputa's contributions to vaccine development exemplify the importance of innovation in addressing public health challenges. His work not only showcases his expertise but also highlights the collaborative efforts that drive scientific advancements.